Intel Announces its First Home Medical Device in the United Kingdom to Better Connect Clinicians With Patients

London, November 20 (ots/PRNewswire) -

- Intel(R) Health Guide is the First Product in a Series Designed
to Enable More Personalised Care Management for Chronic and
Age-related Conditions

Intel Corporation today announced the Intel(R) Health Guide, a
care management tool designed for healthcare professionals who treat
patients with chronic conditions, for the UK. The Intel Health Guide
represents Intel's entry into a new category of personal health
systems that go beyond the simple remote patient monitoring systems
available today.

To view the Multimedia News Release, please click:
http://www.prnewswire.com/mnr/Intel/36076/

The Intel Health Guide, a regulated device that carries the CE
mark under the EU Medical Device Directive, is a comprehensive
personal health system that combines an in-home patient device - the
Intel Health Guide PHS6000 - as well as an online interface - the
Intel(R) Health Care Management Suite - allowing clinicians to
monitor patients in their homes and manage care remotely. Additional
localised European language versions of the Intel Health Guide will
be announced throughout 2009.

"The Intel Health Guide is a step forward in offering more
personalised and effective management of chronic health conditions in
the home," said Louis Burns, vice president and general manager of
the Intel Digital Health Group. "Intel has spent years researching
the needs of healthcare professionals, carers and patients, and we
are now moving to launch a series of products that will help extend
care from the hospital to the home. Our products will help address
the challenges of an ageing population and rising rates of chronic
disease."

The Intel Health Guide promotes greater patient engagement and
more efficient care by enabling communication between patients and
healthcare professionals and providing clinicians with access to the
most current, actionable data. The solution offers interactive tools
for personalised care management and includes vital sign collection,
patient reminders, surveys, multimedia educational content, and
feedback and communications tools, such as video conferencing and
alerts. Clinicians have ongoing access to data so that they can
better manage each patient's condition while patients benefit from
customised care in the comfort of their own home.

Intel is collaborating with healthcare industry leaders in Europe
to demonstrate the clinical benefits of the Intel Health Guide for a
wide range of chronic conditions. European pilots are under way with
healthcare organisations such as NHS Lothian, UK, the Institute for
Prevention and Telemedicine (IPT) and the Academic Medical Center
(AMC), Amsterdam, The Netherlands. The objective is to assess how the
Health Guide integrates with different care management models in the
home. These first studies focus on the ability to demonstrate
improved health outcomes for conditions such as chronic obstructive
pulmonary disease (COPD) and heart failure.

Martin Egan, Director of eHealth, NHS Lothian said, "We are
delighted to be at the heart of this pioneering work through our
pilot programme. Initial findings show that patients experience
additional reassurance from the telehealth system and the early
indications around the reduction of hospital admissions look
promising. We are now working toward the expansion of the programme
across Lothian."

The pilot in The Netherlands is a cooperative effort between the
Academic Medical Center (AMC) in Amsterdam, the Institute for
Prevention and Telemedicine (IPT) and Intel. The project involves
cardiologists and patients from the congestive heart failure (CHF)
outpatient clinic of the AMC under the supervision of Professor Bas
de Mol, Head of the Department of Cardiothoracic Surgery.

Intel is also working with leading organisations that have an
understanding of healthcare delivery to develop unique patient care
plans as well as multimedia educational content for chronic
conditions. In the UK, Intel has worked with the Map of Medicine and
using their existing pathways developed care plans for use on the
Intel Health Guide that are based on best practice and evidence to
help patients and their clinicians effectively manage their condition
at home. Care plans were developed for a number of chronic conditions
including diabetes, heart failure and COPD.

Tunstall Healthcare Group, a leading provider of telecare and
telehealth solutions, is the first official market channel partner
for the Intel Health Guide in the UK. James Buckley, Tunstall CEO
said, "By adding the Intel Health Guide to our portfolio of
healthcare offerings, Tunstall will be further equipped to provide
its customers with the best in care management solutions." Intel is
also currently working with other leading market channel partners in
the UK to bring the Intel Health Guide to market.

The Intel Health Guide is designed to be used by healthcare
professionals to manage their patients' health at home and is not
currently available for general consumer purchase. The Intel Health
Guide received 510(k) market clearance from the U.S. Food and Drug
Administration (FDA) in July 2008 and was announced on Nov. 10, 2008
in the U.S.

Additionally, Intel plans to use the core technology components
of the solution to build products targeted for new areas such as
independent living and programmes for health and wellbeing
management, and to support new devices such as mobile phones and
handhelds.

For More Information

For more information on the Intel Health Guide, visit
http://www.intel.com/healthcare/telehealth.

To learn more about Intel in healthcare, go to
http://www.intel.com/healthcare.

About Intel

Intel (NASDAQ: INTC), the world leader in silicon innovation,
develops technologies, products and initiatives to continually
advance how people work and live. Additional information about Intel
is available at http://www.intel.com/pressroom and blogs.intel.com.

Intel is a trademark of Intel Corporation or its subsidiaries in
the United States and other countries.

* Other names and brands may be claimed as the property of other

Contacts:
Diana Kaaserer Bea Solomon
Intel Corporation Hill and Knowlton
+49-8999143860 +44-2074133185
diana.kaaserer@intel.com bsolomon@hillandknowlton.com

ots Originaltext: Intel Corporation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Contacts: Diana Kaaserer, Intel Corporation, +49-8999143860,
diana.kaaserer@intel.com; Bea Solomon, Hill and Knowlton,
+44-2074133185, bsolomon@hillandknowlton.com